- Home
- PSNYW vs LAB Comparison
PSNYW vs LAB Comparison
Compare PSNYW & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNYW
- LAB
- Stock Information
- Founded
- PSNYW 2017
- LAB 1999
- Country
- PSNYW Sweden
- LAB United States
- Employees
- PSNYW 2547
- LAB N/A
- Industry
- PSNYW Auto Manufacturing
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- PSNYW Consumer Discretionary
- LAB Industrials
- Exchange
- PSNYW Nasdaq
- LAB Nasdaq
- Market Cap
- PSNYW 625.2M
- LAB 504.2M
- IPO Year
- PSNYW N/A
- LAB 2011
- Fundamental
- Price
- PSNYW $0.26
- LAB $1.19
- Analyst Decision
- PSNYW
- LAB Buy
- Analyst Count
- PSNYW 0
- LAB 2
- Target Price
- PSNYW N/A
- LAB $2.50
- AVG Volume (30 Days)
- PSNYW 43.4K
- LAB 1.6M
- Earning Date
- PSNYW 03-06-2025
- LAB 11-04-2025
- Dividend Yield
- PSNYW N/A
- LAB N/A
- EPS Growth
- PSNYW N/A
- LAB N/A
- EPS
- PSNYW N/A
- LAB N/A
- Revenue
- PSNYW $2,034,261,000.00
- LAB $172,271,000.00
- Revenue This Year
- PSNYW N/A
- LAB N/A
- Revenue Next Year
- PSNYW $79.49
- LAB N/A
- P/E Ratio
- PSNYW N/A
- LAB N/A
- Revenue Growth
- PSNYW N/A
- LAB 76.33
- 52 Week Low
- PSNYW $0.09
- LAB $0.92
- 52 Week High
- PSNYW $0.61
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- PSNYW 50.45
- LAB 39.91
- Support Level
- PSNYW $0.23
- LAB $1.26
- Resistance Level
- PSNYW $0.30
- LAB $1.44
- Average True Range (ATR)
- PSNYW 0.04
- LAB 0.09
- MACD
- PSNYW 0.00
- LAB -0.01
- Stochastic Oscillator
- PSNYW 24.34
- LAB 5.44
About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.